Cumulatively, these results strongly suggest that one of the mechanisms by which LAP alleviates adenine-induced cognitive impairment may via modulating SNCA- and/or TGFB1- mediated neuroinflammation. The gene discussed is TGFB2; the disease is Cognitive impairment.